385 related articles for article (PubMed ID: 20152858)
21. Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.
Alhouayek M; Rankin L; Gouveia-Figueira S; Fowler CJ
Br J Pharmacol; 2019 May; 176(10):1470-1480. PubMed ID: 29313885
[TBL] [Abstract][Full Text] [Related]
22. Enzymatic formation of anandamide.
Okamoto Y; Tsuboi K; Ueda N
Vitam Horm; 2009; 81():1-24. PubMed ID: 19647106
[TBL] [Abstract][Full Text] [Related]
23. Effects of orthotopic implantation of rat prostate tumour cells upon components of the N-acylethanolamine and monoacylglycerol signalling systems: an mRNA study.
Alhouayek M; Stafberg L; Karlsson J; Bergström SH; Fowler CJ
Sci Rep; 2020 Apr; 10(1):6314. PubMed ID: 32286386
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
[TBL] [Abstract][Full Text] [Related]
25. Effects of synthetic alkamides on Arabidopsis fatty acid amide hydrolase activity and plant development.
Faure L; Cavazos R; Khan BR; Petros RA; Koulen P; Blancaflor EB; Chapman KD
Phytochemistry; 2015 Feb; 110():58-71. PubMed ID: 25491532
[TBL] [Abstract][Full Text] [Related]
26. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.
Simon GM; Cravatt BF
Mol Biosyst; 2010 Aug; 6(8):1411-8. PubMed ID: 20393650
[TBL] [Abstract][Full Text] [Related]
27. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
Simon GM; Cravatt BF
J Biol Chem; 2006 Sep; 281(36):26465-72. PubMed ID: 16818490
[TBL] [Abstract][Full Text] [Related]
29. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
30. The N-acylethanolamine-mediated regulatory pathway in plants.
Kilaru A; Blancaflor EB; Venables BJ; Tripathy S; Mysore KS; Chapman KD
Chem Biodivers; 2007 Aug; 4(8):1933-55. PubMed ID: 17712835
[TBL] [Abstract][Full Text] [Related]
31. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
[TBL] [Abstract][Full Text] [Related]
32. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the γ Isoform of cPLA
Guo Y; Uyama T; Rahman SMK; Sikder MM; Hussain Z; Tsuboi K; Miyake M; Ueda N
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500646
[TBL] [Abstract][Full Text] [Related]
34. The N-acylation-phosphodiesterase pathway and cell signalling.
Schmid HH; Schmid PC; Natarajan V
Chem Phys Lipids; 1996 May; 80(1-2):133-42. PubMed ID: 8681424
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and preliminary evaluation of N-(16-18F-fluorohexadecanoyl)ethanolamine (18F-FHEA) as a PET probe of N-acylethanolamine metabolism in mouse brain.
Pandey MK; DeGrado TR; Qian K; Jacobson MS; Hagen CE; Duclos RI; Gatley SJ
ACS Chem Neurosci; 2014 Sep; 5(9):793-802. PubMed ID: 25003845
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
38. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period.
Lee TT; Hill MN; Hillard CJ; Gorzalka BB
Synapse; 2013 Jan; 67(1):4-10. PubMed ID: 22987804
[TBL] [Abstract][Full Text] [Related]
39. Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines.
Hussain Z; Uyama T; Tsuboi K; Ueda N
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1546-1561. PubMed ID: 28843504
[TBL] [Abstract][Full Text] [Related]
40. N-acylethanolamine levels and expression of their metabolizing enzymes during pregnancy.
Fonseca BM; Correia-da-Silva G; Taylor AH; Lam PM; Marczylo TH; Konje JC; Bell SC; Teixeira NA
Endocrinology; 2010 Aug; 151(8):3965-74. PubMed ID: 20534733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]